Intelligent Uterine Fibroid Treatment System

Publication ID: 24-11857685_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Uterine Fibroid Treatment System,” Published Technical Disclosure No. 24-11857685_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857685_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,685.

Summary of the Inventive Concept

A comprehensive system integrating collagenase-based treatment with AI, IoT, and blockchain technologies to provide personalized, optimized, and secure uterine fibroid treatment.

Background and Problem Solved

Uterine fibroids affect millions of women worldwide, with current treatments often ineffective or invasive. The original patent's collagenase-based treatment method has limitations in terms of treatment efficacy, dosage optimization, and data tracking. The new inventive concept addresses these limitations by incorporating synergistic technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The system comprises a collagenase-based treatment composition, a blockchain-based tracking module for monitoring treatment efficacy, and a machine learning algorithm for predicting optimal treatment dosages based on patient-specific characteristics. The system can also include IoT-enabled sensors for tracking treatment outcomes and wearable devices for patient monitoring. The AI-powered analytics engine analyzes treatment data, and a visualization dashboard presents treatment outcomes to healthcare providers.

Novelty and Inventive Step

The new claims introduce a synergistic combination of distinct technologies, creating a novel system that overcomes the limitations of the original patent. The integration of AI, IoT, and blockchain technologies with collagenase-based treatment provides a non-obvious solution for personalized and optimized uterine fibroid treatment.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of sensors or wearable devices, integrating additional AI-powered predictive models, or incorporating other blockchain-based data storage modules. Variations may also include adapting the system for treating other types of fibroids or tumors.

Potential Commercial Applications and Market

The Intelligent Uterine Fibroid Treatment System has significant commercial potential in the healthcare industry, particularly in the fields of women's health, oncology, and medical technology. The system's ability to provide personalized and optimized treatment, combined with its secure data tracking and analytics capabilities, makes it an attractive solution for healthcare providers and patients alike.

CPC Classifications

SectionClassGroup
A A61 A61K9/48
A A61 A61K9/0019
A A61 A61K9/0034
A A61 A61K9/1075
A A61 A61K38/43
A A61 A61K38/4886
A A61 A61K45/06
C C12 C12Y304/24003

Original Patent Information

Patent NumberUS 11,857,685
TitleTreatment method and product for uterine fibroids using purified collagenase
Assignee(s)Duke University, BioSpecifics Technologies LLC